PALO ALTO, Calif., April 1, 2015 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced successful completion of a planned interim analysis of its STOP-HE study, a double-blind placebo-controlled study of OCR-002 in patients with acute hepatic encephalopathy (HE). The study's independent Data Monitoring Committee (DMC) reported that the trial is not futile and no drug-related safety signals have been observed in the study. Based on the DMC's recommendation, Ocera will continue the STOP-HE study and will increase target enrollment from 140 patients to approximately 230 patients. The Company remains blinded to data reviewed by the DMC in the interim analysis.
SCOTTSDALE, Ariz., April 1, 2015 (GLOBE NEWSWIRE) -- Spirit Realty Capital, Inc. (NYSE:SRC) ("Spirit"), a real estate investment trust (REIT) that invests in single-tenant, operationally essential real estate, today announced that it has closed a $600 million unsecured credit facility, which initially bears interest at LIBOR plus 170 basis points. The new facility replaces Spirit's previous $400 million facility, which most recently bore interest at LIBOR plus 250 basis points, and improves the borrowing terms as well as the interest rate.
CONWAY, Ark., April 1, 2015 (GLOBE NEWSWIRE) -- Home BancShares, Inc. (Nasdaq:HOMB) ("Home" or "the Company"), parent company of Centennial Bank ("Centennial"), announced today the completion of an acquisition of national commercial real estate loans from J.C. Flowers & Co. LLC totaling approximately $289.1 million. This pool of loans was originated within the former Doral Property Finance portfolio and will now be housed in a division of Centennial known as the Centennial Commercial Finance Group ("Centennial CFG"). The Centennial CFG will be responsible for servicing the acquired loan pool and originating new loan production. The transaction is expected to be immediately accretive to earnings.
NEW YORK, April 1, 2015 (GLOBE NEWSWIRE) -- Morgan & Morgan, P.C. announces that class action lawsuits have been filed in the United States District Court for the Central District of California on behalf of all persons or entities that purchased the common stock of Amira Nature Foods Ltd. ("Amira" or the "Company") (NYSE:ANFI) common stock during the period between September 27, 2012 and February 9, 2015 (the "Class Period"). The complaints allege violations of the Securities Exchange Act of 1934 and the Securities Act of 1933.
GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.